Highlights Cathay Biotech Inc.

Equities

688065

CNE100004447

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
51.3 ^CNY	+4.35%		+24.48%	-6.69%

Apr. 29	Cathay Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 15	Cathay Biotech's Q1 Profit to Surge Up to 100%, Revenue to Climb 43%; Shares Up 6%	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cathay Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 29	CI
Cathay Biotech's Q1 Profit to Surge Up to 100%, Revenue to Climb 43%; Shares Up 6%	Apr. 15	MT
Tranche Update on Cathay Biotech Inc.'s Equity Buyback Plan announced on August 17, 2023.	Apr. 01	CI
Cathay Biotech's 2023 Profit Drops 34% as Revenue Falls 13%	Feb. 25	MT
Cathay Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 23	CI
Cathay Biotech Inc. and 3P.Com Co. Limited Signs Joint Venture Agreement to Propel Sustainable Composite Innovations	Feb. 08	CI
Tranche Update on Cathay Biotech Inc.'s Equity Buyback Plan announced on August 17, 2023.	Jan. 02	CI
Cathay Biotech Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-30	CI
Tranche Update on Cathay Biotech Inc.'s Equity Buyback Plan announced on August 17, 2023.	23-10-09	CI
Cathay Biotech Inc. announces an Equity Buyback for CNY 100 million worth of its shares.	23-08-17	CI
Cathay Biotech Inc. authorizes a Buyback Plan.	23-08-16	CI
Cathay Biotech Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-03	CI
Cathay Biotech Forms Business Cooperation Agreement	23-06-27	MT
HBM Healthcare's Portfolio Company Cathay Biotech to Sell Shares for CNY6.6 Billion	23-06-26	MT
Cathay Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-26	CI
Cathay Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-27	CI
Tranche Update on Cathay Biotech Inc.'s Equity Buyback Plan announced on March 30, 2022.	22-11-30	CI
Cathay Biotech Inc.'s Equity Buyback announced on March 30, 2022, has expired with 1,133,035 shares, representing 0.19% for CNY 94.57 million.	22-11-29	CI
Cathay Biotech Inc. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27	CI
HBM Healthcare Swings To Fiscal H1 Loss On Reduced Share Price Of Portfolio Company Cathay Biotech	22-10-21	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Cathay Biotech Inc.

Equities

688065

CNE100004447

Highlights

Filters